Contrave ER 8-90 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FDK2B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,332
Award facts
- Contract value 100% obligated
- $13,332.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $13,332.37 delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Contrave ER 8-90 mg tablets (120-count units) under firm fixed-price terms. Ultimate completion date is March 9, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside designation and was awarded competitively.
Quick answers
Who was awarded contract SPE2DR26FDK2B?
SPE2DR26FDK2B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 6, 2026.
How much is contract SPE2DR26FDK2B worth?
The government has obligated $13,332 on SPE2DR26FDK2B.
Is contract SPE2DR26FDK2B an order under another contract?
Yes. SPE2DR26FDK2B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDK2B competed?
The extent of competition for SPE2DR26FDK2B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award